Investors

Lucio Rovati and Rottapharm Biotech (Fidim Group)
Lucio Rovati is a physician and clinical pharmacologist, founder and CEO of Rottapharm Biotech. He has a long international experience in research, clinical development and pharmaceutical innovation. Rottapharm Biotech, belonging to the holding company Fidim and founded in 2014, is committed to the research and development of new therapeutic solutions, enhancing consolidated scientific and industrial expertise in the pharmaceutical sector.
www.rottapharmbiotech.com

2invest AG is a listed company that acquires, holds, manages and sells shares in companies and partnerships, mainly - but not exclusively - in the biotechnology, life sciences and IT sectors as well as in the natural resources in Germany and abroad.

Global investments or investments in unlisted companies or financial instruments are also possible. Investment decisions are made on the basis of interesting risk/return profiles.

The company is listed on the General Standard of the Frankfurt Stock Exchange (Ticker: 2INV; ISIN: DE000A3H3L44).